Aurobindo Pharma Limited posts Q3 FY26 revenue growth on Europe strength; margins stable
● Feb 10, 2026
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804) reported higher revenue and profit for the quarter ended Dec. 31, 2025, supported...
